These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 28434702)

  • 1. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.
    Iida Y; Xu B; Schultz GM; Chow V; White JJ; Sulaimon S; Hezi-Yamit A; Peterson SR; Dalman RL
    PLoS One; 2012; 7(12):e49642. PubMed ID: 23226500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
    Wang W; Xu B; Xuan H; Ge Y; Wang Y; Wang L; Huang J; Fu W; Michie SA; Dalman RL
    J Vasc Surg; 2018 Nov; 68(5):1538-1550.e2. PubMed ID: 29242064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
    Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia limits experimental aortic aneurysm progression.
    Miyama N; Dua MM; Yeung JJ; Schultz GM; Asagami T; Sho E; Sho M; Dalman RL
    J Vasc Surg; 2010 Oct; 52(4):975-83. PubMed ID: 20678880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.
    Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Xu B; Xuan H; Iida Y; Miyata M; Dalman RL
    Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation.
    Davis JP; Salmon M; Pope NH; Lu G; Su G; Meher A; Ailawadi G; Upchurch GR
    J Vasc Surg; 2016 Jun; 63(6):1602-1612.e2. PubMed ID: 26817611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
    Kaschina E; Schrader F; Sommerfeld M; Kemnitz UR; Grzesiak A; Krikov M; Unger T
    J Hypertens; 2008 Dec; 26(12):2361-73. PubMed ID: 19008714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms.
    Tanaka H; Xu B; Xuan H; Ge Y; Wang Y; Li Y; Wang W; Guo J; Zhao S; Glover KJ; Zheng X; Liu S; Inuzuka K; Fujimura N; Furusho Y; Ikezoe T; Shoji T; Wang L; Fu W; Huang J; Unno N; Dalman RL
    J Am Heart Assoc; 2021 Sep; 10(17):e022207. PubMed ID: 34459250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms.
    Hamblin M; Chang L; Zhang H; Yang K; Zhang J; Chen YE
    J Vasc Surg; 2010 Oct; 52(4):984-93. PubMed ID: 20630681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
    Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
    Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms.
    Liu S; Huang T; Liu R; Cai H; Pan B; Liao M; Yang P; Wang L; Huang J; Ge Y; Xu B; Wang W
    J Am Heart Assoc; 2020 Apr; 9(8):e014757. PubMed ID: 32308093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse.
    Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
    Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
    Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-188-5p Suppresses Progression of Experimental Abdominal Aortic Aneurysms.
    Huang T; Liu S; Liu R; Pan B; Wang W
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):107-114. PubMed ID: 33105327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.